Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease
Related Experiment Video
Updated: Jan 21, 2026

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
Published on: May 2, 2017
Min-Sun Kim1, Eun-Kyung Kim1, Joon Young Choi2
1Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular and Stroke Institute Imaging Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Insights
Diagnosing pericardial disease is difficult, but [18F]FDG-PET/CT imaging can help. This technique visualizes inflammation and malignancy, aiding in treatment planning and prognosis for pericardial conditions.
Area of Science:
- Nuclear Medicine
- Cardiology
- Oncology
Background:
- Pericardial disease diagnosis is challenging due to limited access to pericardial fluid and tissue.
- Pericardial disease can be an early sign of systemic diseases, necessitating accurate etiological identification.
- Early detection and management of pericarditis are crucial to prevent long-term complications.
Purpose of the Study:
- To review the clinical utility of [18F]-2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) for diagnosing and managing pericardial disease.
- To assess the role of [18F]FDG-PET/CT in differentiating between inflammatory and neoplastic causes of pericardial disease.
- To evaluate the potential of [18F]FDG-PET/CT in guiding anti-inflammatory treatment strategies.
Main Methods:
- Review of existing literature on [18F]FDG-PET/CT applications in pericardial disease.
- Analysis of [18F]FDG-PET/CT imaging characteristics in various pericardial conditions.
- Correlation of imaging findings with clinical outcomes and treatment responses.
Main Results:
- [18F]FDG-PET/CT effectively visualizes hypermetabolic activity in the pericardium, indicative of inflammation or malignancy.
- The pattern of [18F]FDG uptake can help distinguish neoplastic from inflammatory etiologies.
- High pericardial [18F]FDG uptake, after excluding malignancy, suggests active inflammation and predicts response to anti-inflammatory therapy.
Conclusions:
- [18F]FDG-PET/CT is a valuable tool for the diagnosis of pericardial disease, offering insights into etiology.
- The imaging modality aids in establishing prognosis and planning targeted anti-inflammatory treatments.
- [18F]FDG-PET/CT can potentially improve patient outcomes by enabling precise management of pericardial conditions.
Abstract:
Identification of the etiology of pericardial disease is challenging because the accessibility to pericardial fluid and tissue is limited and there is a relatively low yield of fluid and tissue analysis. Pericardial disease is associated with various systemic diseases and is frequently a first manifestation of other systemic diseases. Detecting the cause of pericarditis and minimizing the subsequent inflammatory process can possibly prevent long-term complications. PURPOSE OF REVIEW: To review the clinical utility of [18F]-2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the diagnosis and treatment of pericardial disease. RECENT FINDINGS: [18F]FDG-PET/CT can visualize the hypermetabolic tissues of both malignancy and inflammation. Distribution of [18F]FDG-PET/CT uptake can provide information for neoplastic disease. If malignancy is ruled out, high uptake of pericardium is associated with active inflammation of the pericardium, and thus response to anti-inflammatory agents can also be predicted with [18F]FDG-PET/CT imaging. [18F]FDG-PET/CT can be helpful for diagnosing and establishing prognosis and for planning for anti-inflammatory treatment in pericardial disease.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Coronary Artery Disease III: Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.